News and Research
Immune System
Pacifying Bacteria Prevents Lethal Post-op Infections
2-3-2004
Détente, and a good fence, can be far more effective
than all-out assault in the age-old war between man and
microbe, University of Chicago researchers report in the
February issue of Gastroenterology. By injecting a protective
coating into the intestines to pacify bacteria there instead
of relying on antibiotics to kill them, the scientists were
able to protect mice from otherwise lethal infections.
The
protective coating, a high-molecular-weight polyethylene
glycol, protected mice who had had major surgery from infection
with Pseudomonas aeruginosa, a virulent pathogen that quickly
kills 100 percent of untreated mice. A Pseudomonas infection
is one of the most lethal complications for patients after
major surgery.
"If
you can't beat them -- and you can't -- then you want to
indulge them," says John Alverdy, M.D., associate professor
of surgery at the University of Chicago and director of
the study. "An unhappy parasite is programmed to kill
the host and move on. So we decided to look for ways to
gratify them, to please these powerful microbes and keep
them content."
Pseudomonas
aeruginosa is common, found in the intestines of about three
percent of healthy people. It is also a frequent cause of
hospital-acquired infections, especially after major surgery.
In the bowel, this germ can be harmless, or it can turn
deadly, causing gut-derived sepsis.
|
|
"This is a disease of human progress," explains
Alverdy. When people are severely ill "we put them in intensive
care, where almost every thing we do alarms these bacterial passengers."
Suddenly nutrients no longer pass through the intestines
but are dripped directly into the blood stream. The bowel decreases
its activity, rendering it far less able to contain the toxic effects
of certain strains of bacteria. At the same time, the intestine undergoes
erosion of its protective mucus coating.
"Bacteria are smart enough to sense this change
and re-program their strategy from peaceful coexistence to one in
which harm to their host can occur," Alverdy adds.
Pseudomonas, Alverdy's team has found, detect an ill
host's vulnerability by sensing chemicals that indicate stress. They
respond like a rival nation -- unhappy with its own boundaries and
discovering weakness in a neighbor -- by invading, boring their way
through the bowel wall and into the blood stream.
"At this point, bacteria sense that the host
is vulnerable and a liability to their survival," says Alverdy.
Pseudomonas has tools that let it evade and even disable the host's
immune system. It resists antibiotics and it secretes toxins similar
to those used by diphtheria or anthrax.
"This is the most lethal of the opportunistic
pathogens," he adds. "Patients with widespread Pseudomonas
infection can die in a matter of days."
A coating with a high molecular weight polymer however,
can form a surrogate bioshield, much like the intestine's own mucus,
and stop this whole process before it begins, essentially putting
the bacteria at ease.
It prevents the chemical signals of stress from reaching
the bacteria and triggering the virulent response. It also serves
as a buffer between the bowel wall and the microbes, preventing them
from attaching, the first step to crossing the barrier.
The researchers tested the approach by performing
major surgery on mice, then introducing Pseudomonas into the bowel,
a model that kills all the mice within two days.
One treatment with PEG 15-20, injected into the bowel
at the time of infection, however, completely protected the mice.
A solution taken my mouth four to eight hours after infection also
protected all treated mice.
PEG 15-20 seems to have no adverse effects on the
mice and had no effect on bacterial growth or viability. A lighter
weight PEG, commonly used as an intestinal cleansing agent (Golytely,
PEG-3.35) did not protect mice, although it did have a slight protective
effect in the test tube.
Refinement of this approach, say the authors, could
prevent hospital infections without using antibiotics.
Grants from the National Institutes of Health, the
Packard Foundation and the National Science Foundation supported this
work.
This story has been adapted from a news release issued
by University Of Chicago Medical Center, www.medcenter.uchicago.edu.
Next - Back
to Immune System Support